Status:

ENROLLING_BY_INVITATION

International Registry of Congenital Portosystemic Shunt (IRCPSS)

Lead Sponsor:

Prof. Valérie Mc Lin

Collaborating Sponsors:

European Society of Pediatric Gastroenterology, Hepatology and Nutrition

European Association for the Study of the Liver (EASL)

Conditions:

Congenital Portosystemic Shunt

CPSS (Congenital Portosystemic Shunt)

Eligibility:

All Genders

1+ years

Brief Summary

Congenital Portosystemic Shunt (CPSS) is a rare condition important by the multiplicity and severity of associated complications. CPSS is venous anomaly in which blood coming from the intestines only...

Eligibility Criteria

Inclusion

  • Individual with CPSS

Exclusion

  • Secondary shunt without evidence of congenital shunt

Key Trial Info

Start Date :

April 26 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2028

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT06041906

Start Date

April 26 2018

End Date

December 31 2028

Last Update

June 18 2025

Active Locations (26)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (26 locations)

1

Yale University School of Medicine

New Haven, Connecticut, United States, 06520

2

Lurie Children's Hospital

Chicago, Illinois, United States, 60611

3

Royal Children's Hospital Melbourne

Parkville, Victoria, Australia, 3052

4

Universitary Clinics Saint-Luc, UCL

Brussels, Belgium, 1200

International Registry of Congenital Portosystemic Shunt (IRCPSS) | DecenTrialz